Cyclodextrins as Smart Excipients in Polymeric Drug Delivery Systems

Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications

Volumn , Issue , 2011, Pages 65-89

  Miro, Agnese ^a   Ungaro, Francesca ^a   Quaglia, Fabiana ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biodegradable drug delivery systems based on lipophilic polymers; Cyclodextrins as smart excipients in polymeric drug delivery systems; Polymers, studied for fabrication of extended release hydrophilic matrices

Indexed keywords

EID: 84886461858     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470926819.ch4     Document Type: Chapter

References (99)

1. Swan, E.A., Peppas, N.A. (1981). Drug release kinetics from hydrophobic porous monolithic devices. Proc. Symp. Control. Release Bioact. Mater., 8, 18.
2. Siegel, R.A. (1998). Modeling of drug release from porous systems. In Controlled Release of Drugs. VCH, Weinheim, Germany, p. 51.
3. Ofner, C.M., III, Klech-Gelotte, C.M. (2002). Gels and jellies. In: Encyclopedia of Pharmaceutical Technology, 2nd ed. Swarbrick, J., Boylan, J. C., Eds., Marcel Dekker, New York, pp. 1327-1343.
4. Harada, A., Kamachi, M. (1990). Complex-formation between poly(ethylene glycol) anda-cyclodextrin. Macromolecules, 23, 2821-2823.
5. Li, J., Harada, A., Kamachi, M. (1994). Formation of inclusion complexes of oligoethylene and its derivatives with a-cyclodextrin. Bull. Chem. Soc. Jpn., 67, 2808-2818.
6. Li, J., Harada, A., Kamachi, M. (1994). Sol-gel transition during inclusion complex-formation between a-cyclodextrin and high-molecular-weight poly(ethylene glycol)s in aqueoussolution. Polym. J., 26, 1019-1026.
7. Li, J., Ni, X.P., Leong, K.W. (2003). Injectable drug-delivery systems based on supramolecular hydrogels formed by poly (ethylene oxide) and a-cyclodextrin. J. Biomed. Mater. Res. A, 65, 196-202.
8. Fujita, H., Ooya, T., Yui, N. (1999). Synthesis and characterization of a polyrotaxane consisting of b-cyclodextrins and a poly(ethylene glycol)-poly(propylene glycol) triblock copolymer. Macromol. Chem. Phys., 200, 706-713.
9. Fujita, H., Ooya, T., Yui, N. (1999). Thermally induced localization of cyclodextrins in a polyrotaxane consisting of b-cyclodextrins and poly(ethylene glycol)-poly(propylene glycol) triblock copolymer. Macromolecules, 32, 2534-2541.
10. Agnely, F., Djedour, A., Bochot, A., Grossiord, J.L. (2006). Properties of various thermoassociating polymers: pharmaceutical and cosmetic applications. J. Drug Deliv. Sci. Technol., 16, 3-10.
11. Mayer, B., Klein, C.T., Topchieva, I.N., Kohler, G. (1999). Selective assembly of cyclodextrins on poly(ethylene oxide)-poly(propylene oxide) block copolymers. J. Comput.-Aided Mol. Des., 13, 373-383.
12. Li, J., Loh, X.J. (2008). Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery. Adv. Drug Deliv. Rev., 60, 1000-1017.
13. Olson, K., Chen,Y.Y., Baker, G.L. (2001). Inclusion complexes of a-cyclodextrin and (AB)(n) block copolymers. J. Polym. Sci. A Polym. Chem., 39, 2731-2739.
14. Li, X., Li, J. (2008). Supramolecular hydrogels based on inclusion complexation between poly(ethylene oxide)-bpoly( e-caprolactone) diblock copolymer and a-cyclodextrin and their controlled release property. J. Biomed. Mater. Res. A, 86, 1055-1061.
15. Sarkar, N. (1979). Thermal gelation properties of methyl and hydroxypropyl methylcellulose. J. Appl. Polym. Sci., 24, 1073-1087.
16. Mitchell, K., Ford, J.L., Armstrong, D.J., Elliott, P.N.C., Hogan, C. (1990). The influence of additives on the cloud point, disintegration and dissolution of hydroxypropylmethyl cellulose gels and matrix tablets. Int. J. Pharm., 66, 233-242.
17. Pose-Vilarnovo, B., Rodriguez-Tenreiro, C., Rosa dos Santos, J.F., Vazquez-Doval, J., Concheiro, A., Alvarez-Lorenzo, C., Torres-Labandeira, J.J. (2004). Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J. Control. Release, 94, 351-363.
18. Jug, M., Bećirević-Laćan, M., Kwokal, A., Cetina-Cizmek, B. (2005). Influence of cyclodextrin complexation on piroxicam gel formulations. Acta Pharm., 55, 223-236.
19. Boulmedarat, L., Grossiord, J.L., Fattal, E., Bochot, A. (2003). Influence of methyl-b-cyclodextrin and liposomes on rheological properties of Carbopol 974P NF gels. Int. J. Pharm., 254, 59-64.
20. Kim, E.Y., Gao, Z.G., Park, J.S., Li, H., Han, K. (2002). rhEGF/HP-b-CD complex in poloxamer gel for ophthalmic delivery. Int. J. Pharm.s, 233, 159-167.
21. Dumortier, G., Grossiord, J.L., Agnely, F., Chaumeil, J.C. (2006). A review of Poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res., 23, 2709-2728.
22. Samy, E.M., Safwat, S.M. (1994). In vitro release of antiinflammatory drugs with b-cyclodextrin from hydrophilic gel bases. STP Pharma. Sci., 4, 458-465.
23. Rathnam, G., Narayanan, N., Ilavarasan, R. (2008). Carbopolbased gels for nasal delivery of progesterone. AAPS Pharm-SciTech, 9, 1078-1082.
24. Bilensoy, E., Rouf, M.A., Vural, I., Şen, M., Hincal, A.A. (2006). Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:b-cyclodextrin complex. AAPS PharmSciTech., 7, E38.
25. Peppas, N.A., Ed. (1987) Hydrogels in Medicine and Pharmacy. CRC Press, Boca Raton, FL.
26. Quaglia, F., Varricchio, G., Miro, A., La Rotonda, M.I., Larobina, D., Mensitieri, G. (2001). Modulation of drug release from hydrogels by using cyclodextrins: the case of nicardipine/beta-cyclodextrin system in crosslinked polyethylenglycol. J. Control. Release, 71, 329-337.
27. Tomic, K., Veeman,W.S., Boerakker, M., Litvinov, V.M., Dias, A.A. (2008). Lateral and rotational mobility of some drug molecules in a poly(ethylene glycol) diacrylate hydrogel and the effect of drug-cyclodextrin complexation. J. Pharma. Sci., 97, 3245-3256.
28. Inactive ingredient search for approved drug products. http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm, 2009.
29. Rowe, R.C., Sheskey, P.J., Qinn, M.E., Eds. (2006). Handbook of Pharmaceutical Excipients, 5th ed. Pharmaceutical Press, Chicago.
30. Tiwari, S.B., Rajabi-Siahboomi, A.R. (2008). Extended-release oral drug delivery technologies: monolithic matrix systems. Methods Mol. Biol., 437, 217-243.
31. Conte, U., Giunchedi, P., Maggi, L., La Manna, A. (1993). Erodible matrixes containing hydroxypropyl b-cyclodextrin for linear release of a water-insoluble drug (diazepam). STP Pharma Sci., 3, 242-249.
32. Giunchedi, P., Maggi, L., La Manna, A., Conte, U. (1994). Modification of the dissolution behaviour of a water-insoluble drug, naftazone, for zero-order release matrix preparation. J. Pharm. Pharmacol., 46, 476-480.
33. Sangalli, M.E., Zema, L., Maroni, A., Foppoli, A., Giordano, F., Gazzaniga, A. (2001). Influence of b-cyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials, 22, 2647-2651.
34. Rao, V.M., Haslam, J.L., Stella, V.J. (2001). Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-b-cyclodextrin as a solubilizing agent. J. Pharm. Sci., 90, 807-816.
35. Jug, M., Bećirević-Laćan, M. (2004). Influence of hydroxypropyl-b-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci., 21, 251-260.
36. Singh, S., Jain, S., Muthu, M.S., Tilak, R. (2008). Preparation and evaluation of buccal bioadhesive tablets containing clotrimazole. Curr. Drug Deliv., 5, 133-141.
37. Shanker, G., Kumar, C.K., Gonugunta, C.S., Kumar, B.V., Veerareddy, P.R. (2009). Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS PharmSciTech, 10, 530-539.
38. Cappello, B., De Rosa, G., Giannini, L., La Rotonda, M.I., Mensitieri, G., Miro, A., Quaglia, F., Russo, R. (2006). Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Int. J. Pharm., 319, 63-70.
39. Koester, L.S., Xavier, C.R., Mayorga, P., Bassani, V.L. (2003). Influence of b-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur. J. Pharm. Biopharm., 55, 85-91.
40. Miro, A., Quaglia, F., Giannini, L., Cappello, B., La Rotonda, M.I. (2006). Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. Curr. Drug Deliv., 3, 373-378.
41. Shivakumar, H.N., Desai, B.G., Pandya, S., Karki, S.S. (2007). Influence of b-cyclodextrin complexation on glipizide release from hydroxypropyl methylcellulose matrix tablets. PDA J. Pharm. Sci. Technol., 61, 472-491.
42. Bettini, R., Catellani, P.L., Santi, P., Massimo, G., Peppas, N.A., Colombo, P. (2001). Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate. J. Control. Rel., 70, 383-391.
43. Jug, M., Bećirević-Laćan, M., Bengez, S. (2009). Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol. Drug Dev. Ind. Pharm., 35 (7), 786-807.
44. Ammar, H.O., Salama, H.A., El Nahhas, S.A., Elmotasem, H. (2008). Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr. Drug Deliv., 5, 290-298.
45. Miro, A., Rondinone, A., Nappi, A., Ungaro, F., Quaglia, F., La Rotonda, M.I. (2009). Modulation of release rate and barrier transport of diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery. Eur. J. Pharma. Biopharm., 72, 76-82.
46. Rathbone, M.J., Ponchel, G. Chazali, F.A. (1996). Systemic oral mucosal drug delivery and delivery systems. In: Rathbone, M. J., Ed., Oral Mucosal Drug Delivery. Marcel Dekker, New York.
47. Loftsson, T., Vogensen, S.B., Brewster, M.E., Konradsdóttir, F. (2007). Effects of cyclodextrins on drug delivery through biological membranes. J. Pharm. Sci., 96, 2532-2546.
48. Bibby, D.C., Davies N.M., Tucker, I.G. (2000). Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm., 197, 1-11.
49. Zannou, E.A., Streng,W.H., Stella, V.J. (2001). Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm. Res., 18, 1226-1231.
50. Okimoto, K., Tokunaga, Y., Ibuki, R., Irie, T., Uekama, K., Rajewski, R.A., Stella, V.J. (2004). Applicability of (SBE)7mb-CD in controlled-porosity osmotic pump tablets (OPTs). International Journal of Pharmaceutics, 286, 81-88.
51. Okimoto, K., Rajewski, R.A., Stella, V.J. (1999). Release of testosterone from an osmotic pump tablet utilizing (SBE)7mb-cyclodextrin as both a solubilizing and an osmotic pump agent. J. Control. Rel., 58, 29-38.
52. Okimoto, K., Miyake, M., Ohnishi, N., Rajewski, R.A., Stella, V.J., Irie, T., Uekama, K. (1998). Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-b-CD. Pharm. Res., 15, 1562-1568.
53. Okimoto, K., Ohike, A., Ibuki, R., Aoki, O., Ohnishi, N., Irie, T., Uekama, K., Rajewski, R.A., Stella, V.J. (1999). Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-b-CD. Pharm. Res., 16, 549-554.
54. Okimoto, K., Ohike, A., Ibuki, R., Aoki, O., Ohnishi, N., Rajewski, R.A., Stella,V.J., Irie, T., Uekama, K. (1999). Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-b-CD as both a solubilizer and osmotic agent. J. Control. Rel., 60, 311-319.
55. Sotthivirat, S., Haslam, J.L., Stella, V.J. (2007). Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-b-cyclodextrin, (SBE) 7m-b-CD, as a solubilizing and osmotic agent. J Pharm. Sci., 96, 2364-2374.
56. Sotthivirat, S., Lubach, J.W., Haslam, J.L., Munson, E.J., Stella, V.J. (2007). Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy. J. Pharm. Sci., 96, 1008-1017.
57. Sotthivirat, S., Haslam, J.L., Stella, V.J. (2007). Evaluation of various properties of alternative salt forms of sulfobutyletherb-cyclodextrin, (SBE)7m-b-CD. Int. J. Pharm., 330, 73-81.
58. Sotthivirat, S., Haslam, J.L., Lee, P.I., Rao, V.M., Stella, V.J. (2009). Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-b-cyclodextrin as both a solubilizing and osmotic agent. J. Pharma. Sci., 98, 1992-2000.
59. Uhrich, K.E., Cannizzaro, S.M., Langer, R.S., Shakesheff, K. M. (1999). Polymeric systems for controlled drug release. Chem. Rev., 99, 3181-3198.
60. Markland, P., Yang, V.C. (2002). Biodegradable polymers as drug carriers. In: Swarbrick, J., Boylan, J.C.Eds., Encyclopedia of Pharmaceutical Technology, 2nd Ed. Marcel Dekker, New York, pp. 136-155.
61. Siepmann, J., Siepmann, F. (2009). Time-controlled drug delivery systems. In: Florence, A.T., Siepmann, J.Eds., Modern Pharmaceutics, Vol. 2, Application and Advances. Informa Healthcare, New York, pp. 1-22.
62. Brannon-Peppas, L., Vert, M. (2000). Polylactic and polyglycolic acids as drug delivery carriers. In: Wise, D.L.Ed., Handbook of Pharmaceutical Controlled Release Technology. Marcel Dekker, New York, pp 99-130.
63. Weinberg, B.D., Blanc, E., Ga, J.M. (2008). Polymer implants for intratumoral drug delivery and cancer therapy. Journal of Pharmaceutical Sciences, 97, 1681-1702.
64. Blanco, E.,Weinberg, B.D., Stowe, N.T., Anderson, J.M., Gao, J.M. (2006). Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation. J. Biomed. Materials Research Part A, 76, 174-182.
65. Wang, F., Blanco, E., Ai, H., Boothman, D.A., Gao, J. (2006). Modulating b-lapachone release from polymer millirods through cyclodextrin complexation. J. Pharm. Sci., 95, 2309-2319.
66. Wang, F.J., Saidel, G.M., Gao, J.M. (2007). A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding. J. Control. Release, 119, 111-120.
67. Desai, K.G.H., Mallery, S.R., Schwendeman, S.P. (2008). Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor. Pharm. Res., 25, 586-597.
68. Duchêne, D., Ponchel, G., Wouessidjewe, D. (1999). Cyclodextrins in targeting: application to nanoparticles. Adv. Drug Deliv. Rev., 36, 29-40.
69. Jiang, W., Gupta, R.K., Deshpande, M.C., Schwendeman, S.P. (2005). Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev., 57, 391-410.
70. O'Hagan, D.T., Singh, M., Ulmer, J.B. (2004). Microparticles for the delivery ofDNAvaccines. Immunol. Rev., 199, 191-200.
71. Pawar, R., Ben Ari, A., Domb, A.J. (2004). Protein and peptide parenteral controlled delivery. Expert Opin. Biol. Ther., 4, 1203-1212.
72. Tamber, H., Johansen, P., Merkle, H.P., Gander, B. (2005). Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv. Drug Deliv. Rev., 57, 357-376.
73. Sinisterra, R.D., Shastri, V.P., Najjar, R., Langer, R. (1999). Encapsulation and release of rhodium(II) citrate and its association complex with hydroxypropyl-b-cyclodextrin from biodegradable polymer microspheres. J. Pharm. Sci., 88, 574-576.
74. Yue, I.C., Poff, J., Cortes, M.E., Sinisterra, R.D., Faris, C.B., Hildgen, P., Langer, R., Shastri, V.P. (2004). A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease. Biomaterials, 25, 3743-3750.
75. Trapani, G., Lopedota, A., Boghetich, G., Latrofa, A., Franco, M., Sanna, E., Liso, G. (2003). Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-b-cyclodextrin. Int. J. Pharm., 268, 47-57.
76. Ungaro, F.,De Rosa, G., Miro, A., Quaglia, F., La Rotonda, M.I. (2006). Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci., 28, 423-432.
77. Ungaro, F., d'Emmanuele,V, Giovino, C., Miro, A., Sorrentino, R., Quaglia, F., La Rotonda, M.I. (2009). Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release, 135, 25-34.
78. Morlock, M., Kissel, T., Li, Y.X., Koll, H., Winter, G. (1998). Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J. Control. Release, 56, 105-115.
79. Meinel, L., Illi, O.E., Zapf, J., Malfanti, M., Peter, M.H., Gander, B. (2001). Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. J. Control. Release, 70, 193-202.
80. Murillo, M., Goni, M.M., Irache, J.M., Arangoa, M.A., Blasco, J.M., Gamazo, C. (2002). Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. J. Control. Release, 85, 237-246.
81. Rodrigues Junior, J.M., de Melo, L.K., Matos Jensen, C.E., de Aguiar, M.M., Silva Cunha, J.A. (2003). The effect of cyclodextrins on the in vitro and in vivo properties of insulin-loaded poly (D,L-lactic-co-glycolic acid) microspheres. Artif. Organs, 27, 492-497.
82. Morlock, M., Koll, H., Winter, G., Kissel, T. (1997). Microencapsulation of rh-erythropoietin, using biodegradable poly (d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm., 43, 29-36.
83. Irie, T., Uekama, K. (1999). Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev., 36, 101-123.
84. Castellanos, I.J., Flores, G., Griebenow, K. (2006). Effect of cyclodextrins on a-chymotrypsin stability and loading in PLGA microspheres upon s/o/w encapsulation. J. Pharm. Sci., 95, 849-858.
85. De Rosa, G., Larobina, D., Immacolata, L.R., Musto, P., Quaglia, F., Ungaro, F. (2005). How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-b-cyclodextrin system. J. Control. Release, 102, 71-83.
86. Quaglia, F., De Rosa, G., Granata, E., Ungaro, F., Fattal, E., Immacolata, L.R. (2003). Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly (lactide-co-glycolide) microspheres prepared by spray-drying. J. Control. Release, 86, 267-278.
87. Bala, I., Hariharan, S., Kumar, M.N. (2004). PLGA nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carrier Syst., 21, 387-422.
88. Barratt, G. (2003). Colloidal drug carriers: achievements and perspectives. Cellu. Mol. Life Sci., 60, 21-37.
89. Kayser, O., Lemke, A., Hernandez-Trejo, N. (2005). The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol., 6, 3-5.
90. Couvreur, P., Vauthier, C. (2006). Nanotechnology: intelligent design to treat complex disease. Pharm. Res., 23, 1417-1450.
91. da Silveira, A.M., Ponchel, G., Puisieux, F., Duchêne, D. (1998). Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs. Pharm. Res., 15, 1051-1055.
92. Fresta, M., Fontana, G., Bucolo, C., Cavallaro, G., Giammona, G., Puglisi, G. (2001). Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cy-anoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci,., 90, 288-297.
93. Chen, Y.,Wang, F., Benson, H.A. (2008). Effect of formulation factors on incorporation of the hydrophilic peptide dalargin into PLGA and mPEG-PLGA nanoparticles. Biopolymers, 90, 644-650.
94. Krauland, A.H., Alonso, M.J. (2007). Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm., 340, 134-142.
95. Teijeiro-Osorio, D., Remunan-Lopez, C., Alonso, M.J. (2009). Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur. J. Pharm. Biopharm., 71, 257-263.
96. Teijeiro-Osorio, D., Remunan-Lopez, C., Alonso, M.J. (2009). New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules, 10, 243-249.
97. Shin, K.M., Dong,T., He,Y.,Taguchi,Y., Oishi, A., Nishida, H., Inoue, Y. (2004). Inclusion complex formation between a-cyclodextrin and biodegradable aliphatic polyesters. Macromol. Biosci., 4, 1075-1083.
98. Swarbrick, J., Boylan, J.C. Eds. (2002). Encycopedia of Pharmaceutical Technology, 2nd ed., Marcel Dekker, New York.
99. Batycky, R.P., Hanes, J., Langer, R., Edwards, D.A. (1997). A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci., 86, 1464-1477.